Search

Your search keyword '"Alegret, Montserrat"' showing total 424 results

Search Constraints

Start Over You searched for: Author "Alegret, Montserrat" Remove constraint Author: "Alegret, Montserrat"
424 results on '"Alegret, Montserrat"'

Search Results

1. Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort

2. Genome-wide association study and polygenic risk scores of retinal thickness across the cognitive continuum: data from the NORFACE cohort

3. Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer’s disease spectrum

4. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

5. A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress

6. Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment

7. New insights into the genetic etiology of Alzheimer’s disease and related dementias

8. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

9. Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort

10. Automatized FACEmemory® scoring is related to Alzheimer’s disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort

11. Analysis of shared heritability in common disorders of the brain

12. Analysis of shared heritability in common disorders of the brain.

13. Letter Verbal Fluency in Spanish-, Basque-, and Catalan-Speaking Individuals: Does the Selection of the Letters Influence the Outcome?

14. FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants

15. Predictive Value of the Alzheimer Polygenic Risk Score on Cognitive Decline in Patients with Alzheimer’s Disease Dementia

16. Macular vessel density in the superficial plexus is not associated to cerebrovascular damage in non‐demented individuals: data from the NORFACE cohort

17. Diagnostic performance and clinical applicability of plasma pTau181 to predict dementia risk in a large real‐world cohort of a memory clinic

18. Proteomic analysis reveal early differences in plasma exosomes of Aβ(+) vs Aβ(‐) patients with early‐onset mild cognitive impairment: from BIOFACE to BIOPEXAL study

19. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

20. Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis

21. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

22. Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment

23. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results

24. Letter Verbal Fluency in Spanish-, Basque-, and Catalan-Speaking Individuals: Does the Selection of the Letters Influence the Outcome?

25. FACEmemory®, an innovative online platform for episodic memory pre-screening: findings from the first 3,000 participants

26. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study

27. A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer’s disease

28. Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic

29. Author Correction: Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease

30. Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer’s disease in individuals with mild cognitive impairment: The NORFACE cohort

31. Visual impairment in aging and cognitive decline: experience in a Memory Clinic

32. The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment

33. Clinical Value of Plasma pTau181 to Predict Alzheimer's Disease Pathology in a Large Real-World Cohort of a Memory Clinic

34. Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease

35. Identification of a sex-specific genetic signature in dementia with Lewy bodies: a meta-analysis of genome-wide association studies

36. Additional file 1 of Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment

38. Establishing In-House Cutoffs of CSF Alzheimer’s Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort

39. Complementary pre‐screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project

40. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

41. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type

42. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer’s type

43. Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment

44. Metabolic syndrome impact on cognitive composites domain scores and on white matter hyperintensities in subjective cognitive decline: The FACEHBI Cohort

45. Comparison of automated CLEIA and manual ELISA immunoassays for CSF AD biomarkers: The Fundació ACE Biomarker Research Program (FACEBREP)

47. PLD3 in non-familial Alzheimer's disease

48. From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery

49. Identification of undiagnosed dementia cases using a web-based pre-screening tool: The MOPEAD project

50. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

Catalog

Books, media, physical & digital resources